NEXPOINT ASSET MANAGEMENT, L.P. - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 65 filers reported holding AMRYT PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
NEXPOINT ASSET MANAGEMENT, L.P. ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q3 2022$277,000
-1.1%
40,0000.0%0.02%
-24.0%
Q2 2022$280,000
-15.4%
40,0000.0%0.02%
-41.9%
Q1 2022$331,000
-23.4%
40,0000.0%0.04%
-29.5%
Q4 2021$432,000
-10.7%
40,0000.0%0.06%
-26.5%
Q3 2021$484,000
-0.2%
40,0000.0%0.08%
-21.7%
Q2 2021$485,000
-56.5%
40,000
-50.0%
0.11%
-63.6%
Q1 2021$1,114,000
-1.6%
80,0000.0%0.29%
-21.8%
Q4 2020$1,132,00080,0000.37%
Other shareholders
AMRYT PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders